1. Name Of The Medicinal Product
BurnEze Spray.
2. Qualitative And Quantitative Composition
Benzocaine Ph Eur 1.0% w/w.
3. Pharmaceutical Form
Aerosol spray.
4. Clinical Particulars
4.1 Therapeutic Indications
For the symptomatic relief of pain from minor superficial burns and scalds where the skin is unbroken.
4.2 Posology And Method Of Administration
For topical administration. Adults, the elderly, and children: To reduce pain and blistering, use BurnEze Spray as quickly as possible. Hold nozzle five inches from the skin and spray once for 2-3 seconds. Stop spraying immediately if a white frost deposit (frost) appears. If necessary, the application may be repeated once only after 15 minutes. If pain persists seek medical advice.
4.3 Contraindications
Do not use if you are sensitive to benzocaine.
4.4 Special Warnings And Precautions For Use
Patients with any known allergy should seek medical advice. Do not apply to large areas or to broken skin. Do not use in or near the mouth or eyes or under conditions in which significant inhalation is likely. Avoid freezing the skin by repeated or prolonged use. Seek medical advice immediately if burns are extensive (particularly in young children or if they affect fingers, toes or sensitive areas). For external use only. Keep out of the reach of children. Flammable. Do not use near fire or flame. Pressurised container. Protect from sunlight and do not expose to temperatures exceeding 50oC. Do not pierce or burn, even after use. Do not spray on a naked flame or any incandescent material. Do not use near or place container on polished or painted surfaces.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
None known.
4.6 Pregnancy And Lactation
Safety of use in pregnancy and lactation has not been established.
4.7 Effects On Ability To Drive And Use Machines
None known.
4.8 Undesirable Effects
May cause allergic dermatitis in sensitive individuals.
4.9 Overdose
An overdose is extremely unlikely with this type of preparation.
5. Pharmacological Properties
5.1 Pharmacodynamic Properties
The active ingredient, benzocaine, is a local anaesthetic which relieves pain. The physical effects of the cooling propellants help reduce pain and blistering.
5.2 Pharmacokinetic Properties
BurnEze Spray is applied topically to the affected area.
5.3 Preclinical Safety Data
Not applicable.
6. Pharmaceutical Particulars
6.1 List Of Excipients
Ethanol, Denatured; Isobutane; N-pentane.
6.2 Incompatibilities
None known.
6.3 Shelf Life
Three years.
6.4 Special Precautions For Storage
Do not store above 25oC.
6.5 Nature And Contents Of Container
Aluminium cans (60ml) internally coated with epoxyphenolic lacquer fitted with valve assembly and actuator button, protected by a plastic cap.
6.6 Special Precautions For Disposal And Other Handling
None.
7. Marketing Authorisation Holder
Seton Products Limited, Tubiton House, Oldham, OL1 3HS.
8. Marketing Authorisation Number(S)
PL 11314/0038.
9. Date Of First Authorisation/Renewal Of The Authorisation
15th December 1994 / 13th March 2000./ 16/09/2005
10. Date Of Revision Of The Text
16/09/2005
No comments:
Post a Comment